Sarah has practiced public accounting since 1999 primarily serving clients in the technology and life sciences industries, including software, internet, biotechnology, pharmaceutical and medical device companies. Her expertise also includes working with venture funds and management companies focusing on investment valuation and other complex accounting issues. She consults clients in the application and implementation of new accounting policies and technical guidance in compliance with SEC, SOX 404, and US GAAP requirements.
In addition, she has led numerous initial public offerings and merger and acquisition activities including due diligence and related accounting and SEC reporting. Prior to joining Moss Adams, she spent 20 years at a Big Four firm, where she was most recently a director in the technology practice.